Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013 Nov;163(5):1329-34.e1.
doi: 10.1016/j.jpeds.2013.06.036. Epub 2013 Aug 6.

Antithrombin concentrate use in children: a multicenter cohort study

Affiliations
Multicenter Study

Antithrombin concentrate use in children: a multicenter cohort study

Trisha E Wong et al. J Pediatr. 2013 Nov.

Abstract

Objective: To describe the off-label use of antithrombin concentrate in tertiary care pediatric hospitals across the US.

Study design: This is a retrospective, multicenter, cohort study of 4210 admissions of children younger than 18 years of age who received antithrombin concentrate between 2002 and 2011 within the Pediatric Health Information System administrative database. An on-label admission was defined as an admission with an International Classification of Diseases diagnostic code for a primary hypercoagulable state; admissions without this code were classified as off-label.

Results: During the 10-year study period, off-label use of antithrombin concentrate increased 5-fold. Overall, 97% of study subjects received antithrombin off-label. Neonates younger than 30 days of age comprised the largest age group (45.7%) of use; 87% of patients had at least one complex chronic condition, with congenital heart/lung defects being the most prevalent primary diagnosis (36.3%). Extracorporeal membrane oxygenation was the most common procedure associated with antithrombin use (43.7%).

Conclusions: The off-label use of antithrombin concentrate is increasing rapidly, particularly in critically ill children receiving extracorporeal membrane oxygenation, with few parallel studies to substantiate its safety or efficacy. Further preclinical and controlled clinical studies are critical to expanding our knowledge of this drug. In the meantime, antithrombin concentrate should be used judiciously by clinicians and following guidelines instated by hospitals.

Keywords: CCC; CPB; Cardiopulmonary bypass; Complex chronic conditions; ECMO; Extracorporeal membrane oxygenation; FDA; Food and Drug Administration; ICD-9-CM; International Classification of Diseases, 9thRevision, Clinical Modification; PHIS; Pediatric Health Information System.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
AT use over 10-year study period. (A) AT use within PHIS over time; (B) AT use in ECMO patients within PHIS over time (Off-label = formula image; On-label = formula image)

Similar articles

Cited by

References

    1. Rodgers GM. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Thrombosis and haemostasis. 2009 May;101(5):806–812. - PubMed
    1. Franzen LE, Svensson S, Larm O. Structural studies on the carbohydrate portion of human antithrombin III. The Journal of biological chemistry. 1980 Jun 10;255(11):5090–5093. - PubMed
    1. Edmunds T, Van Patten SM, Pollock J, et al. Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. Blood. 1998 Jun 15;91(12):4561–4571. - PubMed
    1. Olson ST, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. The Journal of biological chemistry. 1992 Jun 25;267(18):12528–12538. - PubMed
    1. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994 May;87(1):106–112. - PubMed

Publication types